مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
Click here for full text options
LibKey Link

مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial (topic), rash/si [Side Effect], respiratory tract infection/si [Side Effect], second cancer/si [Side Effect], skin cancer/si [Side Effect], splenomegaly, subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], very elderly, Waldenstroem macroglobulinemia/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/dt [Drug Therapy], cisplatin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], dexamethasone/dt [Drug Therapy], enoxaparin/cb [Drug Combination], hemoglobin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], ifosfamide/dt [Drug Therapy], immunoglobulin M/ec [Endogenous Compound], lomustine/dt [Drug Therapy], melphalan/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], myeloid differentiation factor 88/ec [Endogenous Compound], ofatumumab/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisone/dt [Drug Therapy], rituximab/dt [Drug Therapy], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/cb [Drug Combination], zanubrutinib/dt [Drug Therapy], zanubrutinib/tm [Unexpected Outcome of Drug Treatment], MYD88 gene, zanubrutinib/pv [Special Situation for Pharmacovigilance], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], cellulitis/si [Side Effect], clinical article, constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], diarrhea/si [Side Effect], drug dose reduction, drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], female, fever/si [Side Effect], gene mutation, headache/si [Side Effect], hemoptysis/si [Side Effect], herpes zoster/si [Side Effect], human, hypertension/si [Side Effect], hyponatremia/si [Side Effect], infection/si [Side Effect], laceration/si [Side Effect], lymphadenopathy, male, monotherapy, multicenter study (topic), muscle spasm/si [Side Effect], neutropenia/si [Side Effect], opportunistic infection/si [Side Effect], overall survival, peripheral edema/si [Side Effect], phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, progression free survival, Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: corticosteroid/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], methylprednisolone/dt [Drug Therapy], prednisolone/dt [Drug Therapy], patient selection, adjuvant therapy, coronary artery aneurysm/dt [Drug Therapy], coronary artery aneurysm/pc [Prevention], corticosteroid therapy, drug effect, editorial, human, mucocutaneous lymph node syndrome/dt [Drug Therapy], priority journal, treatment indication, treatment outcome, acetylsalicylic acid/dt [Drug Therapy], Editorial

URL: Archives of Disease in Childhood
Click here for full text options
LibKey Link

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
LibKey Link

مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial (topic), rash/si [Side Effect], respiratory tract infection/si [Side Effect], second cancer/si [Side Effect], skin cancer/si [Side Effect], splenomegaly, subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], very elderly, Waldenstroem macroglobulinemia/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/dt [Drug Therapy], cisplatin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], dexamethasone/dt [Drug Therapy], enoxaparin/cb [Drug Combination], hemoglobin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], ifosfamide/dt [Drug Therapy], immunoglobulin M/ec [Endogenous Compound], lomustine/dt [Drug Therapy], melphalan/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], myeloid differentiation factor 88/ec [Endogenous Compound], ofatumumab/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisone/dt [Drug Therapy], rituximab/dt [Drug Therapy], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/cb [Drug Combination], zanubrutinib/dt [Drug Therapy], zanubrutinib/tm [Unexpected Outcome of Drug Treatment], MYD88 gene, zanubrutinib/pv [Special Situation for Pharmacovigilance], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], cellulitis/si [Side Effect], clinical article, constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], diarrhea/si [Side Effect], drug dose reduction, drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], female, fever/si [Side Effect], gene mutation, headache/si [Side Effect], hemoptysis/si [Side Effect], herpes zoster/si [Side Effect], human, hypertension/si [Side Effect], hyponatremia/si [Side Effect], infection/si [Side Effect], laceration/si [Side Effect], lymphadenopathy, male, monotherapy, multicenter study (topic), muscle spasm/si [Side Effect], neutropenia/si [Side Effect], opportunistic infection/si [Side Effect], overall survival, peripheral edema/si [Side Effect], phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, progression free survival, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28760Test
Blood Advances
LibKey Link

مصطلحات الفهرس: corticosteroid/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], methylprednisolone/dt [Drug Therapy], prednisolone/dt [Drug Therapy], patient selection, adjuvant therapy, coronary artery aneurysm/dt [Drug Therapy], coronary artery aneurysm/pc [Prevention], corticosteroid therapy, drug effect, editorial, human, mucocutaneous lymph node syndrome/dt [Drug Therapy], priority journal, treatment indication, treatment outcome, acetylsalicylic acid/dt [Drug Therapy], Editorial

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26771Test
Archives of Disease in Childhood
LibKey Link

مصطلحات الفهرس: ulcerative colitis/di [Diagnosis], aminosalicylic acid/ae [Adverse Drug Reaction], aminosalicylic acid/cm [Drug Comparison], aminosalicylic acid/dt [Drug Therapy], aminosalicylic acid/po [Oral Drug Administration], corticosteroid/cm [Drug Comparison], corticosteroid/dt [Drug Therapy], mesalazine/ct [Clinical Trial], mesalazine/cm [Drug Comparison], mesalazine/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], olsalazine/ae [Adverse Drug Reaction], olsalazine/ct [Clinical Trial], olsalazine/cm [Drug Comparison], olsalazine/dt [Drug Therapy], placebo, prednisone/dt [Drug Therapy], salazosulfapyridine/cm [Drug Comparison], salazosulfapyridine/dt [Drug Therapy], salazosulfapyridine/po [Oral Drug Administration], remission, Crohn Disease Activity Index, diarrhea/si [Side Effect], cancer susceptibility, clinical feature, colon cancer/di [Diagnosis], Crohn disease/di [Diagnosis], drug efficacy, drug safety, feasibility study, human, inflammatory bowel disease/di [Diagnosis], interstitial nephritis/si [Side Effect], outcome assessment, pancreatitis/si [Side Effect], pericarditis/si [Side Effect], pleurisy/si [Side Effect], priority journal, Crohn disease/dt [Drug Therapy], review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35354Test
Inflammatory Bowel Diseases
Click here for full text options
LibKey Link

مصطلحات الفهرس: single drug dose, staphylococcal bacteremia/dt [Drug Therapy], staphylococcal bacteremia/si [Side Effect], ventilator associated pneumonia/dt [Drug Therapy], ventilator associated pneumonia/si [Side Effect], Victoria, virus pneumonia/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/pv [Special Situation for Pharmacovigilance], C reactive protein/ec [Endogenous Compound], ceftriaxone/cb [Drug Combination], ceftriaxone/pv [Special Situation for Pharmacovigilance], ferritin/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/cb [Drug Combination], lopinavir plus ritonavir/dt [Drug Therapy], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], noradrenalin/cb [Drug Combination], piperacillin plus tazobactam/cb [Drug Combination], piperacillin plus tazobactam/dt [Drug Therapy], piperacillin plus tazobactam/iv [Intravenous Drug Administration], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], prednisone/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/cb [Drug Combination], tocilizumab/iv [Intravenous Drug Administration], tocilizumab/pv [Special Situation for Pharmacovigilance], vancomycin/dt [Drug Therapy], vancomycin/iv [Intravenous Drug Administration], fraction of inspired oxygen, tocilizumab/dt [Drug Therapy], acute kidney failure/th [Therapy], adult, aged, article, artificial ventilation, Australian, catheter removal, clinical article, coronavirus disease 2019/dt [Drug Therapy], cytokine release syndrome/dt [Drug Therapy], delirium/si [Side Effect], drug withdrawal, endotracheal intubation, eosinophilia/si [Side Effect], extubation, fatty liver, fever, hepatitis/si [Side Effect], human, hypoxia, intensive care, kidney failure/si [Side Effect], male, middle aged, myositis/si [Side Effect], New South Wales, open study, oxygen saturation, oxygen therapy, priority journal, prone position, QT prolongation/si [Side Effect], respiratory failure/th [Therapy], respiratory tract parameters, retrospective study, sedation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28864Test
International Journal of Rheumatic Diseases
Click here for full text options
LibKey Link

مصطلحات الفهرس: histopathology, human, human tissue, inflammatory infiltrate, interstitial nephritis/di [Diagnosis], letter, liver dysfunction, male, physical examination, priority journal, rash, skin edema, sore throat, thrombocytopenia, immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], lamotrigine/ae [Adverse Drug Reaction], methylprednisolone/dt [Drug Therapy], methylprednisolone/iv [Intravenous Drug Administration], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], acute granulomatous tubulointerstitial nephritis/di [Diagnosis], DRESS syndrome/dt [Drug Therapy], fever, acute kidney failure, adult, anuria/th [Therapy], case report, clinical article, DRESS syndrome/di [Diagnosis], DRESS syndrome/si [Side Effect], drug withdrawal, Epstein Barr virus infection/di [Diagnosis], estimated glomerular filtration rate, face edema, fatigue, hemodialysis, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29089Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: infection, kidney disease, macrophage, maintenance therapy, microscopic polyangiitis, monocyte, neutrophil, nonhuman, pathogenesis, pathophysiology, prevalence, priority journal, prognosis, quality of life, respiratory tract disease, review, risk factor, screening, T lymphocyte, treatment duration, Wegener granulomatosis/dt [Drug Therapy], Wegener granulomatosis/et [Etiology], autoantigen/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], cyclophosphamide/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunomodulating agent/dt [Drug Therapy], immunosuppressive agent/dt [Drug Therapy], mepolizumab/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], rituximab/dt [Drug Therapy], eosinophilic granulomatosis with polyangiitis/dt [Drug Therapy], microvasculature, ANCA associated vasculitis/di [Diagnosis], ANCA associated vasculitis/dm [Disease Management], ANCA associated vasculitis/dt [Drug Therapy], ANCA associated vasculitis/ep [Epidemiology], ANCA associated vasculitis/et [Etiology], ANCA associated vasculitis/pc [Prevention], B lymphocyte, biopsy, cardiovascular disease, cellular immunity, clinical feature, clinical trial (topic), comorbidity, complement activation, diagnostic imaging, disease activity, disease association, disease classification, disease severity, environmental factor, genetics, human, incidence, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29087Test
Click here for full text options
LibKey Link